학술논문
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies.
Document Type
Report
Author
Leavenworth JW; Department of Neurosurgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.; The O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.; Department of Microbiology, Heersink School of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.; Liu X; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.; Ma Y; School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Zhu Y; Department of Immunology, School of Biology & Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China.; Qi C; Medical Research Center, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Source
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Subject
Language
English
Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.